144 related articles for article (PubMed ID: 24484329)
1. Fat and cardiotoxicity in hereditary pulmonary hypertension.
Tuder RM; Robinson JC; Graham BB
Am J Respir Crit Care Med; 2014 Feb; 189(3):247-9. PubMed ID: 24484329
[No Abstract] [Full Text] [Related]
2. Evidence for right ventricular lipotoxicity in heritable pulmonary arterial hypertension.
Hemnes AR; Brittain EL; Trammell AW; Fessel JP; Austin ED; Penner N; Maynard KB; Gleaves L; Talati M; Absi T; Disalvo T; West J
Am J Respir Crit Care Med; 2014 Feb; 189(3):325-34. PubMed ID: 24274756
[TBL] [Abstract][Full Text] [Related]
3. Pre-implantation genetic testing for hereditary pulmonary arterial hypertension: promise and caution.
Hamid R; Loyd J
Eur Respir J; 2012 Jun; 39(6):1292-3. PubMed ID: 22654004
[No Abstract] [Full Text] [Related]
4. Waiting in anticipation: the genetics of pulmonary arterial hypertension.
Aldred MA; Morrell NW
Am J Respir Crit Care Med; 2012 Nov; 186(9):820-1. PubMed ID: 23118082
[No Abstract] [Full Text] [Related]
5. Letter by Kataoka et al Regarding Article, "Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle".
Kataoka M; Satoh T; Fukuda K
Circulation; 2016 Aug; 134(9):e115-6. PubMed ID: 27572882
[No Abstract] [Full Text] [Related]
6. Response by van der Bruggen et al to Letter Regarding Article, "Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle".
van der Bruggen CE; Happé CM; Goumans MJ; Bogaard HJ; Vonk Noordegraaf A; de Man FS
Circulation; 2016 Aug; 134(9):e117-8. PubMed ID: 27572883
[No Abstract] [Full Text] [Related]
7. Understanding the low penetrance of bone morphogenetic protein receptor 2 gene mutations: another needle in the haystack.
White RJ; Morrell NW
Circulation; 2012 Oct; 126(15):1818-20. PubMed ID: 23044607
[No Abstract] [Full Text] [Related]
8. Heritable pulmonary arterial hypertension with elevated pulmonary wedge pressure.
Digne F; Sablayrolles JL; Montani D; Laperche T; Rousseau J; Guyon P; Stratiev V; Royer T; Attias D
Circulation; 2012 Aug; 126(9):e124-7. PubMed ID: 22927477
[No Abstract] [Full Text] [Related]
9. MicroRNA-424(322) as a new marker of disease progression in pulmonary arterial hypertension and its role in right ventricular hypertrophy by targeting SMURF1.
Baptista R; Marques C; Catarino S; Enguita FJ; Costa MC; Matafome P; Zuzarte M; Castro G; Reis A; Monteiro P; Pêgo M; Pereira P; Girão H
Cardiovasc Res; 2018 Jan; 114(1):53-64. PubMed ID: 29016730
[TBL] [Abstract][Full Text] [Related]
10. Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle.
van der Bruggen CE; Happé CM; Dorfmüller P; Trip P; Spruijt OA; Rol N; Hoevenaars FP; Houweling AC; Girerd B; Marcus JT; Mercier O; Humbert M; Handoko ML; van der Velden J; Vonk Noordegraaf A; Bogaard HJ; Goumans MJ; de Man FS
Circulation; 2016 May; 133(18):1747-60. PubMed ID: 26984938
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of nuclear factor-κB in the lungs prevents monocrotaline-induced pulmonary hypertension in mice.
Li L; Wei C; Kim IK; Janssen-Heininger Y; Gupta S
Hypertension; 2014 Jun; 63(6):1260-9. PubMed ID: 24614212
[TBL] [Abstract][Full Text] [Related]
12. Rho-kinase inhibition alleviates pulmonary hypertension in transgenic mice expressing a dominant-negative type II bone morphogenetic protein receptor gene.
Yasuda T; Tada Y; Tanabe N; Tatsumi K; West J
Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L667-74. PubMed ID: 21856816
[TBL] [Abstract][Full Text] [Related]
13. Molecular Genetic Diagnosis of Pulmonary Arterial Hypertension: An Increased Complexity.
Eyries M; Soubrier F
Rev Esp Cardiol (Engl Ed); 2016 Nov; 69(11):1003-1004. PubMed ID: 27634583
[No Abstract] [Full Text] [Related]
14. Genetics of pulmonary arterial hypertension.
Elliott CG
Clin Chest Med; 2013 Dec; 34(4):651-63. PubMed ID: 24267296
[TBL] [Abstract][Full Text] [Related]
15. Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.
Meloche J; Courchesne A; Barrier M; Carter S; Bisserier M; Paulin R; Lauzon-Joset JF; Breuils-Bonnet S; Tremblay É; Biardel S; Racine C; Courture C; Bonnet P; Majka SM; Deshaies Y; Picard F; Provencher S; Bonnet S
J Am Heart Assoc; 2013 Jan; 2(1):e005157. PubMed ID: 23525442
[TBL] [Abstract][Full Text] [Related]
16. Genetic ablation of the BMPR2 gene in pulmonary endothelium is sufficient to predispose to pulmonary arterial hypertension.
Hong KH; Lee YJ; Lee E; Park SO; Han C; Beppu H; Li E; Raizada MK; Bloch KD; Oh SP
Circulation; 2008 Aug; 118(7):722-30. PubMed ID: 18663089
[TBL] [Abstract][Full Text] [Related]
17. Seeking the right targets: gene therapy advances in pulmonary arterial hypertension.
Machado RD
Eur Respir J; 2012 Feb; 39(2):235-7. PubMed ID: 22298609
[No Abstract] [Full Text] [Related]
18. Codependence of Bone Morphogenetic Protein Receptor 2 and Transforming Growth Factor-β in Elastic Fiber Assembly and Its Perturbation in Pulmonary Arterial Hypertension.
Tojais NF; Cao A; Lai YJ; Wang L; Chen PI; Alcazar MAA; de Jesus Perez VA; Hopper RK; Rhodes CJ; Bill MA; Sakai LY; Rabinovitch M
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1559-1569. PubMed ID: 28619995
[TBL] [Abstract][Full Text] [Related]
19. The BMPR2 missense mutation p.K230N and pulmonary arterial hypertension.
Hayes D; Ramanathan C; Kopp BT
Pediatr Pulmonol; 2014 Jan; 49(1):E5-6. PubMed ID: 23139147
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary hypertension for clinicians: time to call on genetics?
Reichenberger F
Respiration; 2010; 79(4):274-5. PubMed ID: 19996574
[No Abstract] [Full Text] [Related]
[Next] [New Search]
